DK37489A - Proteiner afledt af human alpha2-plasmininhibitor og dermed beslaegtede proteiner - Google Patents

Proteiner afledt af human alpha2-plasmininhibitor og dermed beslaegtede proteiner

Info

Publication number
DK37489A
DK37489A DK037489A DK37489A DK37489A DK 37489 A DK37489 A DK 37489A DK 037489 A DK037489 A DK 037489A DK 37489 A DK37489 A DK 37489A DK 37489 A DK37489 A DK 37489A
Authority
DK
Denmark
Prior art keywords
proteins
plasmin inhibitor
human alpha2
derived
related proteins
Prior art date
Application number
DK037489A
Other languages
Danish (da)
English (en)
Other versions
DK37489D0 (da
Inventor
Mari Toba
Masahide Tone
Reiko Kikuno
Tamotsu Hashimoto
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of DK37489D0 publication Critical patent/DK37489D0/da
Publication of DK37489A publication Critical patent/DK37489A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK037489A 1988-01-28 1989-01-27 Proteiner afledt af human alpha2-plasmininhibitor og dermed beslaegtede proteiner DK37489A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63015762A JPH01191687A (ja) 1988-01-28 1988-01-28 ヒトα↓２−プラスミンインヒビターまたはそれと類似の蛋白質から誘導される新規蛋白質

Publications (2)

Publication Number Publication Date
DK37489D0 DK37489D0 (da) 1989-01-27
DK37489A true DK37489A (da) 1989-07-29

Family

ID=11897800

Family Applications (1)

Application Number Title Priority Date Filing Date
DK037489A DK37489A (da) 1988-01-28 1989-01-27 Proteiner afledt af human alpha2-plasmininhibitor og dermed beslaegtede proteiner

Country Status (8)

Country Link
EP (1) EP0326013A3 (de)
JP (1) JPH01191687A (de)
KR (1) KR890012001A (de)
AU (1) AU2885689A (de)
DK (1) DK37489A (de)
FI (1) FI890387A7 (de)
IE (1) IE890270L (de)
PT (1) PT89557A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077285A (en) * 1989-07-31 1991-12-31 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
NL8902454A (nl) * 1989-10-03 1991-05-01 Stichting Centraal Lab Mutanten van de humane plasminogeen activator inhibitor 1 (pai-1), hun bereiding en toepassing, en recombinante polynucleotiden die voor deze mutanten coderende genetische informatie omvatten.
GB2271507A (en) * 1992-09-04 1994-04-20 Summit Technology Ireland Bv Compositions containing plasmin activity inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3581328D1 (de) * 1984-06-19 1991-02-21 Transgene Sa Derivate des menschlichen alpha-1-antitrypins und verfahren zu deren herstellung.
DE3521226A1 (de) * 1985-02-08 1986-08-14 Hoechst Ag, 6230 Frankfurt Gene fuer biologisch aktive proteine

Also Published As

Publication number Publication date
JPH01191687A (ja) 1989-08-01
IE890270L (en) 1989-07-28
EP0326013A3 (de) 1990-08-22
FI890387A0 (fi) 1989-01-26
FI890387L (fi) 1989-07-29
KR890012001A (ko) 1989-08-23
DK37489D0 (da) 1989-01-27
PT89557A (pt) 1989-10-04
EP0326013A2 (de) 1989-08-02
FI890387A7 (fi) 1989-07-29
AU2885689A (en) 1989-08-03

Similar Documents

Publication Publication Date Title
DK543189D0 (da) Lysyloxidaseinhibitorer og deres anvendelse
FI916013A7 (fi) Fibrinogeenin määrittäminen kokoverinäytteessä
DK540289D0 (da) Protein
DE68926589D1 (de) Prüfgerät
DK106191D0 (da) Mellemprodukter til fremstilling af penemer og carbapenemer
BR8907457A (pt) Inibidores de interleucina-1
FI912240A7 (fi) Antitrombiineita
FI895962A7 (fi) Proteaasi-inhibiittorit
DK381689D0 (da) Fremgangsmaade til konservering af ophthalmiske oploesninger og midler til anvendelse derved
DK381289D0 (da) Lineaer aktivator
DK273089D0 (da) Anvendelse af peptidderivater
DK406989A (da) Fugtesnekke og fremgangsmaade til rengoering af denne
DK395288D0 (da) Proteiner
FI893451A7 (fi) Uudet proteiinit
FI912412A7 (fi) HDL-sitovat proteiinit
DK37489A (da) Proteiner afledt af human alpha2-plasmininhibitor og dermed beslaegtede proteiner
DK354989D0 (da) Modificerede proteiner
DK0425029T3 (da) Krystallinske aluminophosphater og dermed beslægtede forbindelser
DK562289A (da) Anvendelse af somatostatiner
DK634089A (da) Polyhydroxybenzyloxypropanolaminer og deres anvendelse
DK69489A (da) Aspartattranscarbamylase-inhibitorer
DK417589D0 (da) Fremgangsmaade og kredsloeb til faseforskydning
IT8847653A0 (it) Sizzante comprendente 5 - idroscomposizione farmaceutica anoressitrpofano
DK619589D0 (da) Sphingenin og derivater heraf
KR890015872U (ko) 아이젠

Legal Events

Date Code Title Description
ATS Application withdrawn